AU2164300A - Substituted thiazoles for treatment of human diseases involving modulators of p-, l- and e- selectin - Google Patents
Substituted thiazoles for treatment of human diseases involving modulators of p-, l- and e- selectinInfo
- Publication number
- AU2164300A AU2164300A AU21643/00A AU2164300A AU2164300A AU 2164300 A AU2164300 A AU 2164300A AU 21643/00 A AU21643/00 A AU 21643/00A AU 2164300 A AU2164300 A AU 2164300A AU 2164300 A AU2164300 A AU 2164300A
- Authority
- AU
- Australia
- Prior art keywords
- selectin
- modulators
- treatment
- human diseases
- diseases involving
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11102598P | 1998-12-04 | 1998-12-04 | |
| US11102698P | 1998-12-04 | 1998-12-04 | |
| US60111026 | 1998-12-04 | ||
| US60111025 | 1998-12-04 | ||
| PCT/US1999/028694 WO2000034255A1 (en) | 1998-12-04 | 1999-12-03 | Substituted thiazoles for treatment of human diseases involving modulators of p-, l- and e- selectin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2164300A true AU2164300A (en) | 2000-06-26 |
Family
ID=26808588
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU21643/00A Abandoned AU2164300A (en) | 1998-12-04 | 1999-12-03 | Substituted thiazoles for treatment of human diseases involving modulators of p-, l- and e- selectin |
| AU20398/00A Abandoned AU2039800A (en) | 1998-12-04 | 1999-12-03 | 5-membered heterocycles for the treatment of human diseases involving modulatorsof selectins |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU20398/00A Abandoned AU2039800A (en) | 1998-12-04 | 1999-12-03 | 5-membered heterocycles for the treatment of human diseases involving modulatorsof selectins |
Country Status (2)
| Country | Link |
|---|---|
| AU (2) | AU2164300A (en) |
| WO (2) | WO2000033836A1 (en) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1352641A (en) | 1999-09-29 | 2002-06-05 | 奥索-麦克尼尔药品公司 | Isonipecotamides for the treatment of integrin mediated disorders |
| DE60015594T2 (en) | 1999-11-22 | 2005-10-27 | Smithkline Beecham P.L.C., Brentford | Imidazole derivatives and their use as RAF KINASE INHIBITORS |
| GB0028383D0 (en) | 2000-11-21 | 2001-01-03 | Novartis Ag | Organic compounds |
| AU2002319627A1 (en) | 2001-07-20 | 2003-03-03 | Merck And Co., Inc. | Substituted imidazoles as cannabinoid receptor modulators |
| AU2003202495B2 (en) | 2002-01-11 | 2006-07-20 | Sankyo Company, Limited | Amino alcohol derivative or phosphonic acid derivative and medicinal composition containing these |
| CN101870691A (en) | 2002-08-19 | 2010-10-27 | 劳洛斯治疗公司 | 2,4, the trisubstituted imidazoles of 5-and as the purposes of antiseptic-germicide |
| JP4980715B2 (en) | 2003-05-30 | 2012-07-18 | ジェミン エックス ファーマシューティカルズ カナダ インコーポレイテッド | Tricyclic heterocyclic compounds, compositions and methods for treating cancer or viral diseases |
| DK1692113T3 (en) | 2003-11-14 | 2018-01-08 | Lorus Therapeutics Inc | ARYLIMIDAZOLES AND USE THEREOF AS ANTICANCES |
| US20050148601A1 (en) * | 2003-12-19 | 2005-07-07 | Maynard George D. | Neurokinin-3 receptor modulators: diaryl imidazole derivatives |
| BRPI0506535A (en) | 2004-01-23 | 2007-02-27 | Nereus Pharmaceuticals Inc | Bisindole pyrroles useful as antimicrobial agents |
| WO2005079788A1 (en) | 2004-02-24 | 2005-09-01 | Sankyo Company, Limited | Amino alcohol compound |
| EP1577289A1 (en) | 2004-03-18 | 2005-09-21 | Revotar Biopharmaceuticals AG | Non-glycosylated/-glycosidic/-peptidic small molecule selectin inhibitors for the treament of inflammatory disorders |
| CN101248072B (en) | 2005-05-25 | 2013-01-23 | 劳洛斯治疗公司 | 2-indolyl imidazo[4,5-d]phenanthroline derivatives and their use in the treatment of cancer |
| EP1764093A1 (en) | 2005-09-20 | 2007-03-21 | Revotar Biopharmaceuticals AG | Novel aromatic compounds and their use in medical applications |
| EP1764095A1 (en) | 2005-09-20 | 2007-03-21 | Revotar Biopharmaceuticals AG | Novel nitrocatechol derivatives having selectin ligand activity |
| EP1764096A1 (en) | 2005-09-20 | 2007-03-21 | Revotar Biopharmaceuticals AG | Novel phloroglucinol derivatives having selectin ligand activity |
| EP2086970B1 (en) | 2006-08-24 | 2014-02-26 | Novartis AG | 2-(pyrazin-2-yl)-thiazole and 2-(1h pyrazol-3-yl)-thiazole derivatives as well as related compounds as stearoyl-coa desaturase (scd) inhibitors for the treatment of metabolic, cardiovascular and other disorders |
| EP2066664A1 (en) | 2006-09-22 | 2009-06-10 | Novartis AG | Heterocyclic organic compounds |
| CN101595105B (en) | 2006-12-20 | 2013-01-23 | 诺瓦提斯公司 | 2-substituted 5-membered heterocycles as SCD inhibitors |
| EP2344480A1 (en) | 2008-10-15 | 2011-07-20 | Boehringer Ingelheim International GmbH | Fused heteroaryl diamide compounds useful as mmp-13 inhibitors |
| JP5529876B2 (en) | 2008-10-17 | 2014-06-25 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Heteroaryl-substituted indole compounds useful as MMP-13 inhibitors |
| CA2753972A1 (en) * | 2009-03-04 | 2010-09-10 | Merck Sharp & Dohme Corp. | Imidazole derivatives useful as modulators of faah and as faah imaging agents |
| BR112012000254A2 (en) | 2009-07-08 | 2016-02-16 | Dermira Canada Inc | tofa analogues useful in treating dermatological disorders or conditions. |
| SG11201407919WA (en) | 2012-05-31 | 2014-12-30 | Phenex Pharmaceuticals Ag | Carboxamide or sulfonamide substituted thiazoles and related derivatives as modulators for the orphan nuclear receptor ror[gamma] |
| EP2976342A4 (en) | 2013-03-20 | 2016-08-10 | Aptose Biosciences Inc | 2-substituted imidazo[4,5-d]phenanthroline derivatives and their use in the treatment of cancer |
| KR20160058960A (en) | 2013-10-04 | 2016-05-25 | 압토스 바이오사이언시스 인코포레이티드 | Compositions and methods for treating cancers |
| TW201936190A (en) | 2017-10-30 | 2019-09-16 | 加拿大商艾普托斯生物科學公司 | Aryl imidazoles for the treatment of cancer |
| CN114105881B (en) | 2020-08-31 | 2024-01-26 | 沈阳海诺威医药科技有限公司 | Platelet aggregation inhibitor, and preparation method and application thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3002989A1 (en) * | 1980-01-29 | 1981-07-30 | Hoechst Ag, 6000 Frankfurt | HYDROXYPHENYL-THIAZOLE, -THIAZOLINE AND -THIAZOLIDINE-CARBONIC ACIDS, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE FOR INFLUENCING COLLAGEN METABOLISM |
| US5753687A (en) * | 1995-06-19 | 1998-05-19 | Ontogen Corporation | Modulators of proteins with phosphotryrosine recognition units |
-
1999
- 1999-12-03 AU AU21643/00A patent/AU2164300A/en not_active Abandoned
- 1999-12-03 WO PCT/US1999/028692 patent/WO2000033836A1/en active Application Filing
- 1999-12-03 AU AU20398/00A patent/AU2039800A/en not_active Abandoned
- 1999-12-03 WO PCT/US1999/028694 patent/WO2000034255A1/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| WO2000033836A1 (en) | 2000-06-15 |
| WO2000033836A9 (en) | 2001-10-04 |
| WO2000034255A9 (en) | 2001-10-04 |
| AU2039800A (en) | 2000-06-26 |
| WO2000034255A1 (en) | 2000-06-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2164300A (en) | Substituted thiazoles for treatment of human diseases involving modulators of p-, l- and e- selectin | |
| AU6913796A (en) | Patient treatment apparatus | |
| AU4582797A (en) | Methods for treatment of retinal diseases | |
| AU6579498A (en) | Compounds and methods for the diagnosis and treatment of (ehrlichia) infection | |
| AU6412296A (en) | Massage appliance for body massage | |
| AU7931194A (en) | Apparatus for treatment of the oral cavity | |
| AU3891299A (en) | Combination therapy for treatment of depression | |
| AU2463099A (en) | Gabapentin and its derivatives for the treatment of muscular and skeletal pain | |
| AU2141600A (en) | Device for external treatment of the oral cavity by means of light and method for medical treatment | |
| AU3784999A (en) | Methods for treatment of pain | |
| AU8038998A (en) | Prophylactic or therapeutic agent for diseases attributable to infection with helicobacters | |
| AU7728698A (en) | Oral formulations for treatment of bacteria-induced diseases of the colon | |
| AU8869398A (en) | Medical apparatus for relief of pain | |
| AU3896900A (en) | Treatment of pain | |
| AU2194399A (en) | Device for therapeutical treatment of a blood vessel | |
| AU5713196A (en) | Method for treatment of pain | |
| GB2303303B (en) | Medical treatment | |
| AU9337598A (en) | Magnetically therapeutic treatment device | |
| AU6829696A (en) | Treatment of solutions | |
| AU1181897A (en) | Medical use of proteases | |
| GB9521725D0 (en) | Medical treatment | |
| AU2566201A (en) | Compounds and methods for the treatment of pain | |
| AU2462097A (en) | The use of a substance p antagonist for the manufacture of medicament for the treatment of ocular pain | |
| AU1405001A (en) | Treatment of diseases | |
| AU3632899A (en) | Method for the therapeutic and prophylactic treatment of dental diseases |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |